Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Contract/Agreement, Product/Service

Florence Healthcare Supports Pfizer's COVID-19 Vaccine Clinical Trials with Extensive Connectivity Platform

Today, Florence announced a collaboration with Pfizer to support a global Phase 2/3 COVID-19 vaccine study. Florence is the largest site and sponsor connectivity platform in the industry, with more than 7,200 research sites and 18,000 research professionals leveraging the platform across 27 countries. This extensive network of connectivity supports the COVID-19 trial by ensuring research can continue and thrive in a digital capacity, as onsite visits and collaboration are restricted due to the pandemic.

In addition to a vast network of connectivity, Florence is uniquely equipped to support the advancement of COVID-19 vaccine trials due to its advanced suite of products. With support from Florence's Remote Site Monitoring Module, coupled with the use of eBinders, Pfizer was able to accelerate remote site access as it commenced a global safety and efficacy clinical trial of an mRNA-based vaccine candidate against SARS-CoV-2 in July 2020.

"We're very proud to work with Pfizer on this vital trial," says Ryan Jones, CEO of Florence. "It's meaningful work to be able to support a company that's at the forefront of innovation for the benefit of the global community. We will continue our support to help ensure Pfizer has everything it needs from a clinical trial software perspective to be successful."

"Florence's platform is helping us to respond to the changing environment due to COVID-19 and further progress COVID-19 research with the capability to perform remote monitoring where approved by regulatory authorities and ethics committees," said Rob Goodwin, Vice President and Head of the Operations Center of Excellence in Global Product Development at Pfizer.


Based in Atlanta, Florence is the leading platform for remote connectivity and electronic document workflow management in clinical research and is considered the industry standard with more than 7,200 research sites in 26 countries, sponsors and CROs collaborating on its network. Florence advances clinical trials through software for managing document and data flow between research sites and sponsors. Florence solutions foster 25% faster start-up time and 40% reduced document cycle time, among other benefits. To learn about advancing research through collaboration, visit www.florencehc.com.

These press releases may also interest you

at 23:05
Technavio has been monitoring the automotive engine oil market and it is poised to grow by 876.17 million L during 2020-2024, progressing at a CAGR of over 3% during the forecast period. The report offers an up-to-date analysis regarding the current...

at 22:05
Impossible Foods is making its award-winning, plant-based meat available to home chefs in Asia in nearly 200 grocery stores across Hong Kong and Singapore -- the first time Impossible Beef Made From Plants has been available for home chefs outside of...

at 22:05
Heilind Asia Pacific, part of Heilind Electronics Inc., was invited to attend the "6th Edition Electronics Maker Best Awards 2020" Virtual Ceremony held on 15th October 2020 to meet the world's leading companies in the electronic components industry....

at 22:05
The global interactive kiosk market size is poised to grow by USD 4.79 billion during 2020-2024, progressing at a CAGR of almost 4% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis...

at 22:00
After one year of waiting and careful planning, the 25th China (Guzhen) International Lighting Fair (GILF) will be held at Guzhen Convention and Exhibition Center, Zhongshan City, Guangdong Province, from October 22 to 26, 2020. With the great...

at 22:00
transcosmos inc. will be the exclusive sales partner to HERO, a virtual shopping app provided by Hero Towers Limited (Headquartered in London and New York). Hero powers the virtual shopping experience for global fashion brands like Nike, Levi's and...

News published on 2 september 2020 at 07:35 and distributed by: